CLINICAL_TRIALS
trial_result
· 2019-01-03
Clinical Trial Update: Clobetasol for Oral Graft-Versus-Host Disease [Phase 2]
Summary
Phase 2 trial evaluating clobetasol for oral chronic graft-versus-host disease has been completed, with results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Oral Chronic Graft vs Host Disease | Phase 2 | Status: COMPLETED | Results posted: 2019-01-03